. Accessed November 07, 2022. https://www.statista.com/statistics/266528/revenue-distribution-of-roche-pharmaceuticals-by-therapy-area/, Roche. Show all statistics (4) . The next Annual General Meeting of Roche Holding Ltd is expected to take place on 14 March 2023. This text provides general information. Players, stakeholders, and other participants in the global Critical Process Vessels market will be [], Final Report will add the analysis of the impact of COVID-19 on this industry. Global Ultra-Low Alpha Metals Replacing Hazardous Materials Market Report has been [], Copyright 2022 ", Roche, Revenue distribution of Roche's Pharmaceuticals division in 2020 and 2021, by therapeutic area Statista, https://www.statista.com/statistics/266528/revenue-distribution-of-roche-pharmaceuticals-by-therapy-area/ (last visited November 07, 2022), Revenue distribution of Roche's Pharmaceuticals division in 2020 and 2021, by therapeutic area, Cancer deaths worldwide by major type 2020, U.S. Americans with a history of cancer living 2004-2022, Number of new cancer cases in U.S. from 1999 to 2018, Spending and growth worldwide in oncology market 2022-2026, Oncology medicine spending growth 2014-2018, by region, Predicted oncology spending in 2023, by region, Emerging cancer diagnostics market size by world region 2015 and 2023, Oncology therapeutic market growth U.S. 2016-2021, by segment, Global top pharmaceutical companies by oncology market share 2017 and 2024, Revenue share of Roche's Pharmaceuticals division by therapy area 2020-2021, Bristol-Myers Squibb's top products based on revenue 2016-2021, U.S. venture investments in oncology companies 2006-2022, U.S. oncology company IPO money raised 2006-2021, Top 5 worldwide oncology products by revenue 2017 and 2024, Top 5 worldwide oncology products by market share 2017 and 2024, Availability of new cancer drugs by country as of 2018, Top U.S. oncology products by revenue in 2016, Number of cancer drugs by cost and number of patients U.S. 2017, FDA on breakthrough therapy requests by therapy area 2019, FDA on breakthrough therapy requests granted by therapy area 2019, Distribution of late phase oncology pipeline 2008 vs. 2018 by type, Number of cancer drugs in development in the U.S. 2005-2018, Time from R&D start to approval of select cancer drugs 2017, Total R&D costs including costs of capital for select cancer drugs 2017, Worldwide top drug producing mechanisms of action by number of active compounds 2022, Distribution of the immuno-oncology pipeline worldwide 2018, by mechanism of action, Global cancer immunotherapy market size 2016 and 2022 forecast, Global cancer immunotherapy sales share by type 2021 forecast, Leading cancer immunotherapy collaborations worldwide by value 2018, Distribution of treatment types for female breast cancer by stage 2018, Distribution of treatment types for prostate cancer 2010-2012, Distribution of treatment types for colon cancer by stage 2018, Distribution of treatment types for lung cancer in the U.S. 2018, Distribution of treatment types for non-Hodgkin lymphoma 2013, Number of oncologists per one million people by select country 2018, Number of hours U.S. oncologists spend a week seeing patients 2018, Number of minutes U.S. oncologists spend with each patient 2018, Cancer patients using medication in select countries 2018, Cancer sufferers based on lifestyle habits by select country 2019, Inpatient average length of stay in U.S. hospitals by cancer type 2008-2017, Spending growth of top pharmaceutical therapeutic classes by CAGR 2014-2018, Pharmaceutical industry - sales growth by therapeutic classes, Global pharmaceutical pipeline by therapy area 2013-2017, Global pharmaceutical product launches by therapy area 2004-2013, Sales of the top pharmaceutical therapeutic areas, Total per-study costs by clinical trial phase and therapeutic area, Sales growth of pharmaceutical therapeutic areas, Distribution of U.S. pharma licensing deals by therapeutic area 2016, Number of active clinical trials and studies in Australia by therapeutic class 2014, Global medicine spending share by disease forecast 2020, New medicine availability by therapy area worldwide 2013, Global precision medicine market size by application 2017, Global precision medicine market CAGR projection by application 2017-2028, U.S. drug development phase I to approval success rates 2011-2020 by disease area, Number of Canadian clinical specialists 2019, by therapeutic area, Leading therapy areas by commercial PMPM spending U.S. 2019, Jazz Pharmaceuticals sales in 2021, by therapy area, Digital health applications in the United Kingdom (UK) 2013, by therapy area, Life sciences M&A value of portfolio optimization worldwide by therapeutic area 2020, Change in Medicare PMPM spending in top drug categories 2018-2019, Find your information in our database containing over 20,000 reports, Find a brief overview of all Outlooks here, Tools and Tutorials explained in our Media Centre. At 2 February 2022, based on information supplied to the Group, a shareholder group with pooled voting rights owned 72,018,000 shares representing 67.50% of the issued shares. Quick Analysis with our professional Research Service: Toplists & Rankings: Best Employers Portal, Show sources information Get in touch with us. Diagnostics sales of Roche in 2021, by customer area (in million Swiss francs) [Graph]. Chart. New, Insights into the worlds most important health markets, Figures and insights about the advertising and media world, Everything you need to know about the industry development. (February 3, 2022). facts. 1.2.5 Plant cells "Revenue distribution of Roche's Pharmaceuticals division in 2020 and 2021, by therapeutic area." Facebook: quarterly number of MAU (monthly active users) worldwide 2008-2022, Quarterly smartphone market share worldwide by vendor 2009-2022, Number of apps available in leading app stores Q2 2022, Research expert covering health, pharma & medtech, Profit from additional features with an Employee Account. Corporate solution including all features. . 1.2.1 Global Cell Lysis & Disruption Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 Roche. Learn more about how Statista can support your business. Roche's expenses by type 2019-2021. Similar Reports: Global and United States Cell Lysis & Disruption Market Report & Forecast 2022-2028, Global Cell Lysis & Disruption Market Insights and Forecast to 2028, Cell Lysis & Disruption Market Global Outlook and Forecast 2022-2028, Global Cell Lysis & Disruption Market Size, Status and Forecast 2021-2027, https://www.24marketreports.com/latest ArticlesRead Morelatest Articleslatest Publications, Milk Slice Market report discusses key sectoral trends to analyze the near-term growth of industry. At 2 February 2022, based on information supplied to the Group, Ms Maja Oeri, formerly a member of the pool, held 8,091,900 shares independently of the pool, representing 7.58% of the issued shares. International: (+1) 646 781 7170 / +91 8087042414 1.2 Market Analysis by Type The Company has a share capital of CHF 106,691,000, divided into 106,691,000 fully paid bearer shares with a nominal value of 1 Swiss franc each. . facts. 210'426. Use Ask Statista Research Service, Number of active physicians in the U.S. 2022 by specialty area, Number of oncology specialty physicians in the U.S. 2016, Global oncology revenue by top ten pharmaceutical companies 2017 and 2024. Use Ask Statista Research Service, Countries with the highest number of diabetics 2021, Diabetics prevalence worldwide 2021, 2030. and 2045, Countries with the highest prevalence of diabetes 2021. If you are an admin, please authenticate by logging in again. a) Each non-voting equity security (Genussschein) confers the same rights as any of the shares to participate in the available earnings and any remaining proceeds from liquidation following repayment of the nominal value of the shares and the participation certificate capital (if any). The most important key figures provide you with a compact summary of the topic of "Roche" and take you straight to the corresponding statistics. The share capital of Roche Holding Ltd, which is the Groups parent company, amounts to CHF 106,691,000 consisting of 106,691,000 fully paid up bearer shares with a nominal value of CHF 1 each. Statista. c) 2021 dividend proposed by the Board of Directors. liability for the information given being complete or correct. Please create an employee account to be able to mark statistics as favorites. Then you can access your favorite statistics via the star in the header. Cell Lysis & Disruption market is segmented by players, region (country), by Type and by Application. Show publisher information 1.3.2 Protein Isolation [], GlobalMobile Payment Security SoftwareMarket Report is an objective and in-depth study of the current state aimed at the major drivers, Mobile Payment Security Software [], Critical Process Vessels market is segmented by Type and by Application. Overview and forecasts on trending topics, Industry and market insights and forecasts, Key figures and rankings about companies and products, Consumer and brand insights and preferences in various industries, Detailed information about political and social topics, All key figures about countries and regions, Everything you need to know about Consumer Goods, Identify market potentials of the digital future, Insights into the world's most important technology markets, Health Market Outlook facts. We provide the names of institutions for your convenience only. Roches American Depositary Receipt (ADR) is listed on OTCQX International Premier under the ticker RHHBY. 3 Competition Landscape by Key Players Roches non-voting equity securities and the rights pertaining thereto are described in 4ss. 2017. We do not endorse or express any opinion on their reports and expressly disclaim any liability for any of their statements and for the use of such third party information. Revenue distribution of Roche's Pharmaceuticals division in 2020 and 2021, by therapeutic area [Graph]. Year. 2 Global Growth Trends The ideal entry-level account for individual users. Bizberg Themes, https://www.24marketreports.com/report-sample/global-cell-lysis-disruption-2022-356, https://www.24marketreports.com/life-sciences/global-cell-lysis-disruption-2022-356, Global and United States Cell Lysis & Disruption Market Report & Forecast 2022-2028, Milk Slice Market to Witness Huge Growth by 2030 Mead Johnson, HiPP, Danone, Nestle, Abbott, Arla, Heinz, Bellamy, Mobile Payment Security Software Market Size & Revenue Analysis | Cryptzone, Axway, Splunk, SnoopWall, Zscaler, Critical Process Vessels Market Insights, Forecast to 2028, Global Ultra-Low Alpha Metals Replacing Hazardous Materials Market Analysis 2022: Explosive Growth Opportunity (with CAGR), Regional Growth, Current Trend, Challenges, Potential Benefits till 2025. 1.1 Study Scope Overview and forecasts on trending topics, Industry and market insights and forecasts, Key figures and rankings about companies and products, Consumer and brand insights and preferences in various industries, Detailed information about political and social topics, All key figures about countries and regions, Everything you need to know about Consumer Goods, Identify market potentials of the digital future, Insights into the world's most important technology markets, Health Market Outlook 2018. Market capitalization of Roche (ROG.SW) Market cap: $270.69 Billion As of November 2022 Roche has a market cap of $270.69 Billion.This makes Roche the world's 26th most valuable company by market cap according to our data. ", Roche, Diagnostics sales of Roche in 2021, by customer area (in million Swiss francs) Statista, https://www.statista.com/statistics/1288621/roche-diagnostics-sales-by-customer-area/ (last visited November 07, 2022), Diagnostics sales of Roche in 2021, by customer area, Distribution of causes of death worldwide in 2019, Main causes of treatable mortality across OECD countries 2019, Number of diabetics worldwide by age group 2017 and 2045, Number of diabetics worldwide by region 2021, Children and type 1 diabetes worldwide - key facts 2021, Diabetes prevalence adults in selected countries 2021, Top countries by new cases rate of type 1 diabetes in children 2021, Undiagnosed diabetes cases globally by region 2021, Share of undiagnosed diabetics by world region 2021, Number of diabetes deaths worldwide 2021, by region, Deaths by diabetes mellitus in the U.S. 1950-2019, Death rate for diabetes mellitus in Canada 2000-2020, Most common cause of death in Mexico 2021, Deaths related to diabetes in Europe in 2021, by country, Estimated diabetes-related deaths in China 2015-2021, Top 10 countries with highest spending per person with diabetes 2021, Top 10 countries with lowest spending per person with diabetes 2021, Average cost per person with diabetes globally by region 2021, Health care expenditure due to diabetes worldwide by region 2021, Diabetes health expenditure top 10 countries in 2021, Healthcare expenditures due to diabetes in the U.S. and China 2021, Global healthcare expenditure due to diabetes in 2007, 2021, 2030, and 2045, Novo Nordisk sales in diabetes subsegments 2021, Sanofi pharmaceutical segment revenues by product group 2021, Sanofi top pharmaceutical products 2017-2021, Abbott's Medical Devices segment revenue by category 2021, Diagnostics sales of Roche by customer area 2021, Distribution of Medtronic's revenue by segment 2020-2022, Becton, Dickinson, and Company's medical revenues in 2019-2021 by segment, Projected number of diabetics worldwide by region 2045, Change in number of diabetics between 2021 and 2045 by world region, Countries with the highest projected number of diabetics 2045, Top therapy classes by spending global market 2026 forecast, Value of top M&A medical technology company deals worldwide 2021, Global medical technology top companies by market share 2021 and 2028, Medical technology - top companies based on revenue 2021, Number of U.S. and European medical technology companies 2009-2020, Value of M&A medical technology company deals worldwide 2011-2021, Predicted top medical technology companies by revenue 2028, Number of companies in the medical technology industry in Italy 2022, by category, Global top companies by medical technology R&D spending 2021 and 2028, U.S. and European medical technology companies - total revenues 2009-2020, Medical technology companies in the U.S. and Europe - net income 2009-2020, U.S. and European medical technology companies - R&D expenditure 2009-2020, U.S. and European medical technology companies - number of employees 2009-2020, Number of M&A deals in medical technology worldwide 2011-2021, Size of the medical technology market in Spain 2015-2021, Total value of medtech venture capital investments globally 2008-2021, Value of top ten medtech venture financing deals globally 2021, Value of top ten medtech IPO deals globally 2021, Individuals employed in the medical technology sector in Europe in 2021, Medical technology sector employment in the United Kingdom (UK) 2020, by region, Employment rate in the medical technology sector in Europe in 2021, Medical technology market share based on manufacturer prices in Europe 2020, Diagnostics sales of Roche in 2021, by customer area (in million Swiss francs), Find your information in our database containing over 20,000 reports, Find a brief overview of all Outlooks here, Tools and Tutorials explained in our Media Centre. Get full access to all features within our Corporate Solutions. Show publisher information According to the latest research, the market size of the Genomic Data Analysis and Interpretation industry in 2021 will increase by USD million compared to 2020, with a growth rate of %. Powered by WordPress Directly accessible data for 170 industries from 50 countries Profit from the additional features of your individual account. Year-end. This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Roche's non-voting equity securities and Roche bearer shares are listed on SIX Swiss Exchange. 2.3 Cell Lysis & Disruption Market Dynamics Xaralite Currently, you are using a shared account. and over 1Mio. It provides key research findings, along with projected data points. In 2009, the duration of the pool was extended for an indefinite period. 3.1 Global Top Cell Lysis & Disruption Players by Revenue As the global economy recovers in 2021 and the supply of the industrial chain improves, the Genomic Data Analysis and Interpretation market will undergo major changes. Then you can access your favorite statistics via the star in the header. Facebook: quarterly number of MAU (monthly active users) worldwide 2008-2022, Quarterly smartphone market share worldwide by vendor 2009-2022, Number of apps available in leading app stores Q2 2022, Research expert covering health & pharmaceuticals in the UK & Europe, Profit from additional features with an Employee Account. The list may be updated from time to time, but no assurance is given that the list is current or accurate as of any point in time. This investor tool provides advanced analysis of total returns over time including dividend history and a calculator that can be used to determine the value and total return of your investment. 267'684. Quarterly smartphone market share worldwide by vendor 2009-2022 . 2.3.1 Cell Lysis & Disruption Industry Trends Profit from the additional features of your individual account. Chart. data than referenced in the text. Our anniversary year was no exception: In 2021 our more than 100,000 employees and our partners developed, manufactured and provided global access to state-of-the-art diagnostics and treatments for serious diseases, particularly for COVID-19. The shareholder pooling agreement has existed since 1948. 276 5th Avenue, New York , NY 10001,United States Quick Analysis with our professional Research Service: Toplists & Rankings: Best Employers Portal, Show sources information Learn more about how Statista can support your business. Accessed November 07, 2022. https://www.statista.com/statistics/1288621/roche-diagnostics-sales-by-customer-area/, Roche. Satellite Phone and VHF/UHF Radio works where traditional communication is difficult or impossible. These figures do not include any shares without pooled voting rights held outside this group by individual members of the group. 1 Report Overview Statista. & Clear filter. New, Insights into the worlds most important health markets, Figures and insights about the advertising and media world, Everything you need to know about the industry development. Declaration date is the date of approval of the proposed dividend at the Annual General Meeting, Ex-dividend date is the first date where trading takes place without dividend, Record date is the last date on which the security must be held in custody in order to be eligible to receive dividend (as settlement typically takes place trading day + 3 days). To use individual functions (e.g., mark statistics as favourites, set Beginning in 2019, Roche Holding Ltd dividend to ADR holders will be paid in two stages. Clicking on the following button will update the content below. The share capital of Roche Holding Ltd, which is the Group's parent company, amounts to CHF 106,691,000 consisting of 106,691,000 fully paid up bearer shares with a nominal value of CHF 1 each. and over 1Mio. Players, stakeholders, and other participants in the global Cell Lysis & Disruption market will be able to gain the upper hand as they use the report as a powerful resource. F. Hoffmann-La Roche Ltd. Qiagen NV. Please do not hesitate to contact me. 1.3.1 Global Cell Lysis & Disruption Market Share by Application: 2017 VS 2021 VS 2028 If you are an admin, please authenticate by logging in again. New, Insights into the worlds most important health markets, Figures and insights about the advertising and media world, Everything you need to know about the industry development. 2.1 Global Cell Lysis & Disruption Market Perspective (2017-2028) Shares and non-voting equity securities are listed on the SIX Swiss Exchange. In addition, 702,562,700 non-voting equity securities have been issued in bearer form. Roche Holding Ltd has no restrictions as to ownership of its shares or non-voting equity securities. Designed by 1.5 Years Considered Currently, you are using a shared account. Find your information in our database containing over 20,000 reports, Find a brief overview of all Outlooks here, Tools and Tutorials explained in our Media Centre, based on prescription drug sales worldwide, is the most revenue-generating therapeutic area worldwide, pharmaceutical giant Novartis is also based in Basel, acquisition of U.S. company Genentech in 2009, the Swiss company will remain at the top of R&D spenders by 2026, Roche is among the leading companies by number of drugs in development. 1.3.4 Cell Organelle Isolation In, Roche. 2021 dividend . The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Equity research on Roche is provided by the following institutions. 1.3.5 Nucleic Acid Isolation 2019. To use individual functions (e.g., mark statistics as favourites, set 2.2.1 Cell Lysis & Disruption Market Size by Region: 2017 VS 2021 VS 2028 2.3.2 Cell Lysis & Disruption Market Drivers Those eligible holders reclaiming Swiss withholding tax will receive a second payment once the reclaim process is completed. of the Articles of Incorporation of Roche Holding Ltd. For more information, please read the Articles of Incorporation. Roche's oncology share of pharmaceuticals revenue in 2021, Estimated total global pharmaceutical R&D spending in 2021, Number of products in Roche's R&D pipeline in 2022, Research expert covering health, pharma & medtech. There are no limitations on the transfer of these shares and no shares with maximum voting rights (please refer to 3ss. Quick Analysis with our professional Research Service: Toplists & Rankings: Best Employers Portal. 207'328. This statistic shows pharmaceutical company Roche's top diagnostic products in 2021, based on sales in certain customer areas. The first payment will be less 35% Swiss withholding tax, payable one week after Swiss pay date. All rights reserved. All important statistics are prepared by our experts available for direct download as PPT & PDF! Get full access to all features within our Corporate Solutions. As the shares are bearer shares, the Group does not maintain a register of shareholders. 2.2.2 Cell Lysis & Disruption Historic Market Size by Region (2017-2022) statistic alerts) please log in with your personal account. We are happy to help. Market capitalisation in millions of CHF. Revenue share of Roche's Pharmaceuticals division by therapy area 2020-2021, Pharmaceutical company Roche: top drugs based on revenue 2020-2021, Total global pharmaceutical R&D spending 2014-2028, Global top pharmaceutical companies based on R&D spending 2026, Top pharma companies worldwide 2022, by size of R&D pipeline, Facebook: quarterly number of MAU (monthly active users) worldwide 2008-2022, Quarterly smartphone market share worldwide by vendor 2009-2022, Number of apps available in leading app stores Q2 2022, Value of Roche's acquisition of Genentech in 2009, Pharmaceutical market: worldwide revenue 2001-2021, Top 50 pharmaceutical companies - Rx sales and R&D spending 2021, 2021 list of global top 10 biotech and pharmaceutical companies by employees, Gross margin based ranking of top pharmaceutical companies 2021, Top companies by COVID-19 treatment vaccines in development June 2022, Operating profit of the Roche Group 2007-2021, Roche Group's total sales by division 2013-2021, Distribution of Roche's Pharmaceuticals division revenues 2014-2021, Diagnostics sales of Roche by customer area 2021, Johnson & Johnson's total sales 2005-2021, R&D spending share of top pharmaceutical companies 2019 and 2026, Roche's expenditure on research and development 2011-2021, Top pharma companies worldwide by number of originated drugs 2022. Dear Shareholders, Since its founding 125 years ago, Roche has worked to improve the health and lives of countless people all over the world. "Revenue Distribution of Roche's Pharmaceuticals Division in 2020 and 2021, by Therapeutic Area. February 3, 2022. Directly accessible data for 170 industries from 50 countries b) All stock price data reflect daily closing prices. 2.2.3 Cell Lysis & Disruption Forecasted Market Size by Region (2023-2028) 2.3.4 Cell Lysis & Disruption Market Restraints Operating profit of the Roche Group 2007-2021. 1.3.1 Global Cell Lysis & Disruption Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Protein Isolation 1.3.3 Downstream Processing 1.3.4 Cell Organelle Isolation 1.3.5 Nucleic Acid Isolation Due to varying update cycles, statistics can display more up-to-date 1.2.2 Mammalian cells (February 3, 2022). Are you interested in testing our corporate solutions? of the Articles of Incorporation of Roche Holding Ltd.). 3.1.1 Global Top Cell Lysis & Disruption Players by Revenue (2017-2022) and over 1Mio. TS2 Space. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. 1.2.4 Yeast/Algae/Fungi Bio-Rad Laboratories, Inc. Miltenyi Biotec GmbH. 2020. . 2.2 Cell Lysis & Disruption Growth Trends by Region 1.3.3 Downstream Processing Becton Dickinson & Company (BD) Danaher Corporation. February 3, 2022. 2.3.3 Cell Lysis & Disruption Market Challenges The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a . Directly accessible data for 170 industries from 50 countries 3.1.2 Global, CONTACT US: In, Roche. statistic alerts) please log in with your personal account. In the following 5 chapters, you will quickly find the 24 most important statistics relating to "Roche". 1.4 Study Objectives Number of bearer shares (nominal value CHF 1.-), Number of non-voting equity securities (NES), Roche Non-Voting Equity Securities and Roche Bearer Shares, Number of shares (nominal value: CHF 1.00), Number of non-voting equity securities (Genussscheine) (no nominal value), Equity attributable to Roche shareholders, Stock price of non-voting equity security (Genussschein) b), Dividend yield of non-voting equity securities (Genussscheine) in %, Price/earnings of non-voting equity securities (Genussscheine). Overview and forecasts on trending topics, Industry and market insights and forecasts, Key figures and rankings about companies and products, Consumer and brand insights and preferences in various industries, Detailed information about political and social topics, All key figures about countries and regions, Everything you need to know about Consumer Goods, Identify market potentials of the digital future, Insights into the world's most important technology markets, Health Market Outlook Statista assumes no Revenue share of Roche's Pharmaceuticals division by therapy area 2020-2021 Celgene's top product revenues 2013-2018 Bristol-Myers Squibb's top products based on revenue 2016-2021 1.2.3 Bacterial cells Roche. "Diagnostics sales of Roche in 2021, by customer area (in million Swiss francs)." 1.3 Market by Application Since 5 December 2019, the shareholder group consists of Mr Andr Hoffmann, Ms Marie-Anne Hoffmann, Ms Vera Michalski, Mr Alexander Hoffmann, Mr Frederic Hoffmann, Ms Isabel Hoffmann, Mr Lucas Hoffmann, Ms Marina Hoffmann, Ms Kasia Barbotin-Larrieu, Ms Tatiana Fabre, Mr Andreas Oeri, Ms Catherine Oeri, Ms Sabine Duschmal, Mr Jrg Duschmal, Mr Lukas Duschmal, the charitable foundation Wolf and Artuma Holding Ltd. You only have access to basic statistics. Please create an employee account to be able to mark statistics as favorites.